Author

P. J. McMurrick

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:statistical model· 1

Frequent Co-Authors

H. E. Abud· 2 shared T. Jarde· 2 shared A. M. Kane· 1 shared B. A. Leggett· 1 shared B. Salik· 1 shared C. E. Bond· 1 shared C. Su· 1 shared D. M. McKeone· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

H. E. Abud

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Aspirin synergizes with regorafenib to reduce growth of colorectal cancer

C. Su, L. J. Fennell, C. E. Bond, A. M. Kane, G. Kerr, T. Jarde, D. Micati, R. M. Engel, W. H. Chan, S. Hlavca, S. Archer, P. J. McMurrick, H. Hammerlindl, F. Lim, B. Salik, , V. L. Whitehall

This study shows that aspirin and regorafenib together reduce colorectal cancer growth in preclinical models by inhibiting the PI3K-Akt-mTOR pathway and activating AMPK.

bioRxiv · Feb 11, 2022 · PreprintCancer Biology

SRSF3 confers selective processing of miR-17-92 cluster to promote tumorigenic properties in colorectal cancer

M. Ratnadiwakara, R. Engel, T. Jarde, P. J. McMurrick, H. E. Abud, M.-L. Anko

This study identifies SRSF3's role in selectively processing miR-17-92 cluster miRNAs, promoting tumorigenic properties in colorectal cancer by inhibiting CDKN1A and enhancing cell cycle progression.

bioRxiv · Jun 11, 2019 · PreprintCell Biology